deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03308643

Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital

Conditions Myomectomy
Interventions Oxytocin saline
Updated 6 times since 2017 Last updated: May 17, 2018 Started: Oct 1, 2017 Primary completion: May 10, 2018 Completion: May 10, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Myomectomy and is currently completed. Kanuni Sultan Suleyman Training and Research Hospital leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

▶ Show 1 earlier version

  1. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kanuni Sultan Suleyman Training and Research Hospital
Data source: Kanuni Sultan Suleyman Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations